Models for all outcomes except glucose tolerance tests included fixed effects for cohort (YA, OAP, and OAG), study time (0-, 2-, and 16-weeks), and cohort-time interaction term
A meta-analysis also showed that weight loss, but not a reduced HbA1c level, was significantly and independently associated with BP reductions in GLP-1RA and SGLT2 inhibitor treatment [4]
IDEAL was carried out in four Scandinavian countries and included 8864 patients with cardiovascular disease, of whom 7782 (87.8%) had normal levels of aminotransferases and 1081 (12.2%) elevated levels of ALT, possibly due to NAFLD/NASH
No matter how they arrived here, most share a similar question: How do I take this medication and still care for myselfwhile maintaining a healthy, peaceful relationship with food and my body? This is where GLP-1 nutrition comes ina way of supporting your bodys needs with compassion, structure, and flexibility, while staying true to a non-diet, weight-inclusive approach